Latest News | Lupin Gets USFDA Approval for Cyanocobalamin Nasal Spray

New Delhi, Jul 3 (PTI) Pharma major Lupin Ltd on Monday said it has received approval from the US health regulator for its generic version of Cyanocobalamin nasal spray.

The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Cyanocobalamin nasal spray of strength 500 mcg/spray (one spray per device), Lupin said in a statement.

Also Read | Kartik Aaryan Box Office: SatyaPrem Ki Katha is Actor’s Second-Highest Opening Weekend, Check Out His Top 5 First Weekend Collections.

Cyanocobalamin nasal spray is used to maintain normal vitamin B12 blood levels in patients with pernicious anaemia.

"This product will be manufactured at Lupin's Somerset facility in the US," the company added.

Also Read | UPSC IFS Result 2023: Union Public Service Commission Declares Indian Forest Service Final Exam Results at upsc.gov.in, Get Direct Link and Know Steps To Check Scores.

Cyanocobalamin nasal spray had estimated annual sales of USD 69 million in the US, Lupin said, citing IQVIA MAT March 2023 data.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)